What does this research mean for the field?

SLE-DAS demonstrates superior accuracy in assessing disease activity compared to SLEDAI-2 K in a Chinese cohort. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The study aims to validate the SLE-DAS for assessing disease activity in systemic lupus erythematosus compared to SLEDAI-2-K.

March 12, 2026Open Access

Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in a Chinese Cohort: Comparison with SLEDAI-2-K

Key Points

The study aims to validate the SLE-DAS for assessing disease activity in systemic lupus erythematosus compared to SLEDAI-2-K.
Comparison of SLE-DAS and SLEDAI-2-K scores in a Chinese cohort
Assessment of nephritis and hematological manifestations
Analysis of baseline scores relative to organ damage
SLE-DAS showed superior accuracy over SLEDAI-2-K in assessing disease activity
Baseline SLE-DAS positively associated with short-term organ damage accrual
Need for long-term validation of findings noted

Abstract

SLE-DAS demonstrates superior accuracy in assessing disease activity compared to SLEDAI-2 K, likely attributable to refinements in assessing nephritis and hematological manifestations. Baseline SLE-DAS also exhibited a positive association with short-term organ damage accrual, though long-term validation is required.

Bookmark

View Full Paper

Bookmark

View Full Paper

Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in a Chinese Cohort: Comparison with SLEDAI-2-K

Key Points

Abstract

Cite This Study